Inverted T-shape Free Gingival Graft for Treatment of RT2 / RT3 Gingival Recession Defects

Launched by CAIRO UNIVERSITY · Sep 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new technique called the inverted T-shape free gingival graft, which is being compared to a standard free gingival graft. Both methods aim to help patients with specific types of gum recession (known as recession type 2 and type 3) in the lower front teeth area. The goal is to see if the new graft shape can better improve gum attachment, cover exposed tooth roots, and increase the width of healthy gum tissue.

To participate in this study, individuals must be between 18 and 40 years old and have specific types of gum recession. They should also be in good overall health and able to maintain proper oral hygiene. The trial is looking for patients who are willing to follow up for 6 months after the procedure. However, certain people, like smokers or those with specific dental issues, won’t be able to join. Participants can expect to receive treatment and follow-up care over the study period, contributing to important research that could improve gum treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with RT2/RT3 gingival recession.
• • Indication for FGG treatment at mandibular incisor area (i.e., difficulty or discomfort during oral hygiene; gingival margin mobility; high muscle attachment and/or frenum pull; shallow vestibule and gingival recession.
• • KT width (KTW) \< 2 mm.
• • Ages 18-40 years old.
• • Patients with healthy systemic condition (Brightman. 1994).
• • Gingival and plaque index \<10.
• • Good oral hygiene (Wiesner et al. 2010).
• • Accepts 6 months follow-up period (cooperative patients)
• Exclusion Criteria:
• • Smokers.
• • Poor oral hygiene.
• • Patient with a physical disability that hinders the upkeep of good oral hygiene measures.
• • Intake of any medications known to affect gingival homeostasis or to interfere with wound healing.
• • Pregnant or lactating women.
• • RT1 gingival recession.
• • Caries or non-carious cervical lesions at recipient sites.
• • Severely malpositioned teeth.
• • Teeth with residual probing depth ≥ 4 mm.
• • Mobility ≥ 1 mm.
• • Pervious periodontal surgery within the last 6 months before the start of the trial.
• • Patients with active periodontal disease. -